KeDong Biotechnology Overview
- Year Founded
-
2022
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
3
KeDong Biotechnology General Information
Description
Developer of suppressor tRNA therapies and adeno-associated virus (AAV)-based delivery platforms designed to address severe diseases caused by premature termination codons. The company's products are developed through advanced technologies such as suppressor tRNA screening and optimization, as well as AAV vector delivery systems, enabling them to restore protein function and address previously untreatable conditions through advanced genetic therapies.
Contact Information
Website
www.codonebio.comCorporate Office
- Number 1077 Zhangheng Roadv
- Pudong New Area
- Shanghai, 519000
- China
Corporate Office
- Number 1077 Zhangheng Roadv
- Pudong New Area
- Shanghai, 519000
- China
KeDong Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 13-Nov-2024 | Completed | Generating Revenue | |||
| 1. Secondary Transaction - Private | 24-Apr-2024 | Completed | Generating Revenue |
KeDong Biotechnology Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Elikon Venture | Growth/Expansion | Minority | ||
| Zhongjun Capital | Venture Capital | Minority | ||
| CDBI Partners | Venture Capital | Minority |
KeDong Biotechnology FAQs
-
When was KeDong Biotechnology founded?
KeDong Biotechnology was founded in 2022.
-
Where is KeDong Biotechnology headquartered?
KeDong Biotechnology is headquartered in Shanghai, China.
-
What industry is KeDong Biotechnology in?
KeDong Biotechnology’s primary industry is Biotechnology.
-
Is KeDong Biotechnology a private or public company?
KeDong Biotechnology is a Private company.
-
What is KeDong Biotechnology’s current revenue?
The current revenue for KeDong Biotechnology is .
-
Who are KeDong Biotechnology’s investors?
Elikon Venture, Zhongjun Capital, and CDBI Partners have invested in KeDong Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process